Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6276
Global X FinTech ETF
FINX
$168M
| $1.34M | ﹤0.01% |
+62,767
| New | +$1.61M |
|
6277
Nuveen ESG Emerging Markets Equity ETF
NUEM
$417M
| $1.34M | ﹤0.01% |
+48,983
| New | +$1.38M |
|
|
CCF
6278
DELISTED
Chase Corporation
CCF
| $1.34M | ﹤0.01% |
17,187
+2,198
| +15% | +$180K |
|
6279
PUT
Hecla Mining
HL
$12.6B
| $1.34M | ﹤0.01% |
340,700
-50,900
| -13% | -$265K |
|
|
SRNE
6280
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.33M | ﹤0.01% |
664,422
-1,029,400
| -61% | -$1.78M |
|
6281
Future Fuel
FF
$245M
| $1.33M | ﹤0.01% |
183,010
-28,332
| -13% | -$238K |
|
6282
CALL
Champion Homes
SKY
$5.13B
| $1.33M | ﹤0.01% |
28,100
-25,000
| -47% | -$1.29M |
|
6283
Snap
SNAP
$9.15B
| $1.33M | ﹤0.01% |
101,556
-5,697,705
| -98% | -$130M |
|
|
NVEI
6284
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $1.33M | ﹤0.01% |
36,860
-151,219
| -80% | -$7.88M |
|
6285
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $1.33M | ﹤0.01% |
54,160
+22,140
| +69% | +$546K |
|
6286
Cabaletta Bio
CABA
$466M
| $1.33M | ﹤0.01% |
1,254,479
-220,621
| -15% | -$312K |
|
|
KLDW
6287
DELISTED
Knowledge Leaders Developed World ETF
KLDW
| $1.33M | ﹤0.01% |
+37,373
| New | +$1.43M |
|
6288
CALL
Kosmos Energy
KOS
$1.51B
| $1.33M | ﹤0.01% |
214,700
+151,300
| +239% | +$1.09M |
|
|
ASLN
6289
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $1.33M | ﹤0.01% |
66,628
-895
| -1% | -$19.9K |
|
6290
BGC Group
BGC
$5.33B
| $1.33M | ﹤0.01% |
393,779
-849,733
| -68% | -$2.96M |
|
6291
CALL
OR Royalties Inc
OR
$6.25B
| $1.33M | ﹤0.01% |
131,300
+20,200
| +18% | +$242K |
|
|
TSVT
6292
DELISTED
2seventy bio
TSVT
| $1.33M | ﹤0.01% |
+100,490
| New | +$1.37M |
|
6293
iShares MSCI UAE ETF
UAE
$312M
| $1.33M | ﹤0.01% |
+85,413
| New | +$1.5M |
|
|
ACRE
6294
CALL
Ares Commercial Real Estate
ACRE
$262M
| $1.32M | ﹤0.01% |
108,100
+76,400
| +241% | +$1.11M |
|
6295
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
| $1.32M | ﹤0.01% |
+29,547
| New | +$1.34M |
|
6296
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.42B
| $1.32M | ﹤0.01% |
47,100
-230,600
| -83% | -$9.17M |
|
6297
PUT
Anavex Life Sciences
AVXL
$298M
| $1.32M | ﹤0.01% |
131,900
+7,800
| +6% | +$73.9K |
|
6298
CALL
ProShares Short QQQ
PSQ
$606M
| $1.32M | ﹤0.01% |
18,340
+14,140
| +337% | +$943K |
|
6299
CALL
State Street Blackstone Senior Loan ETF
SRLN
$5.44B
| $1.32M | ﹤0.01% |
+31,700
| New | +$1.38M |
|
6300
PUT
Azenta
AZTA
$1.46B
| $1.32M | ﹤0.01% |
18,300
-600
| -3% | -$44.8K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.